Bradford Crutchfield - 12 Jan 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
12 Jan 2022
Net transactions value
-$2,003,299
Form type
4
Filing time
14 Jan 2022, 15:32:12 UTC
Previous filing
23 Dec 2021
Next filing
17 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $19,720 +17,000 +17% $1.16 114,653 12 Jan 2022 Direct F1
transaction TXG Class A Common Stock Sale $728,071 -6,195 -5.4% $117.53 108,458 12 Jan 2022 Direct F1, F2
transaction TXG Class A Common Stock Sale $613,499 -5,185 -4.8% $118.32 103,273 12 Jan 2022 Direct F1, F3
transaction TXG Class A Common Stock Sale $121,311 -1,017 -0.98% $119.28 102,256 12 Jan 2022 Direct F1, F4
transaction TXG Class A Common Stock Sale $133,025 -1,100 -1.1% $120.93 101,156 12 Jan 2022 Direct F1, F5
transaction TXG Class A Common Stock Sale $389,648 -3,200 -3.2% $121.76 97,956 12 Jan 2022 Direct F1, F6
transaction TXG Class A Common Stock Sale $12,294 -100 -0.1% $122.94 97,856 12 Jan 2022 Direct F1
transaction TXG Class A Common Stock Sale $12,353 -100 -0.1% $123.53 97,756 12 Jan 2022 Direct F1
transaction TXG Class A Common Stock Sale $12,444 -100 -0.1% $124.44 97,656 12 Jan 2022 Direct F1
transaction TXG Class A Common Stock Sale $375 -3 -0% $125.00 97,653 12 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -17,000 -4% $0.000000 409,000 12 Jan 2022 Class A Common Stock 17,000 $1.16 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $116.89 to $117.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $117.90 to $118.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $118.985 to $119.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $120.31 to $121.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $121.47 to $122.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This option, originally for 800,000 shares, of which 391,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.